official impact factor

1.94

Advanced search

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk

R Andrew Moore^*, Sheena Derry and Henry J McQuay

* Corresponding author: R Andrew Moore andrew.moore@pru.ox.ac.uk

BMC Musculoskeletal Disorders 2007, 8:73 doi:10.1186/1471-2474-8-73

Accesses

Last 30 days: 64 accesses
Last 365 days: 730 accesses
All time: 7415 accesses

Cited by

BioMed Central: 4 citations

Systematic review of dexketoprofen in acute and chronic pain

R Andrew Moore, Jodie Barden BMC Clinical Pharmacology 2008, 8:11 (31 October 2008)

Abstract | Full text | PDF | PubMed

New horizons and perspectives in the treatment of osteoarthritis

Francis Berenbaum Arthritis Research & Therapy 2008, 10(Suppl 2):S1 (17 October 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Perioperative celecoxib administration for pain management after total knee arthroplasty – A randomized, controlled study

Yu-Min Huang, Chiu-Meng Wang, Chen-Ti Wang, Wei-Peng Lin, Lih-Ching Horng, Ching-Chuan Jiang BMC Musculoskeletal Disorders 2008, 9:77 (3 June 2008)

Abstract | Full text | PDF | PubMed

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs

R Andrew Moore, Sheena Derry, Henry J McQuay, John Paling Arthritis Research & Therapy 2008, 10:R20 (7 February 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations